Article
Identification of a novel de novo gain-of-function mutation of PIK3CD in a patient with activated phosphoinositide 3-kinase δ syndrome.
Clinical immunology (Orlando, Fla.) - 1 Dec 2018
Luo Ying, Xia Yu, Wang Wenjing, Li Zhichuan, Jin Yan, Gong Yifeng, He Tingyan, Li Qiu, Li Chengrong, Yang Jun
Abstract excerpt
Activated phosphoinositide 3-kinase δ (PI3Kδ) syndrome is a newly defined and relatively common primary immunodeficiency, which is caused by heterozygous gain-of-function (GOF) mutations in PIK3CD or PIK3R1. Here, we report a novel de novo GOF mutation (c.1570 T > A, p.Y524N) in PIK3CD in a 6-year-old Chinese girl. The patient suffered recurrent sinopulmonary infection, bronchiectasis, lymphoproliferation,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
